Phaedra Chrousos, Director at Vanda Pharmaceuticals Inc. (VNDA), sold 2,075 shares at $19.34 ($40K) on 2021-06-14, disclosed to the SEC on 2021-06-15.
Open-market sale of $40k VNDA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.